Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
220
datasets available to search
ShareScore release 0.9.0
Dataset results
220 results for “Alzheimer dementia”
Alzheimer's Disease and Related Dementias (ADRD) Prevalence in American Samoa
ClinicalTrials.gov study NCT05924529. IPD Sharing: YES. Countries: 1. Publications: 1.
Low Dose Ionizing Radiation Using CT Scans as a Potential Therapy for Alzheimer's Dementia: A Pilot Study
ClinicalTrials.gov study NCT03597360. IPD Sharing: NO. Countries: 1. Publications: 17.
Healthy lifestyle and the risk of Alzheimer's dementia: Findings from two longitudinal studies
Open the record for dataset details and reuse information.
Dataset for research: "MTA and Koedam Score Contributes to Cognitive Impairment in Probable Alzheimer, Vascular and Mixed Dementia: A Memory Clinic Study in Indonesia"
<p>This is a dataset for research : "MTA and Koedam Score Contributes to Cognitive Impairment in Probable Alzheimer, Vascular and Mixed Dementia: A Memory Clinic Study in Indonesia"</p> <h1><strong><span>Abstract</span></strong></h1> <p><strong><span>Background</span></strong><span>. Medial Temporal Atrophy (MTA) and Parietal Atrophy (Koedam score) have been used in clinical practice to help the diagnosis of Alzheimer’s disease. However, the role of this brain imaging marker in early detection of other type of dementia remains elusive. The study aims to investigate the association between MTA and Koedam scores with the cognitive function in dementia patients (Alzheimer, vascular and mixed dementia).</span></p> <p><strong><span>Method</span></strong><span> <span>This was a</span> cross-sectional study using<span> data from a</span> Memory Clinic in Dr. Sardjito General Hospital Yogyakarta, Indonesia. The data was collected from January 2020 until December 2022. We collected the data regarding demographic and clinical characteristics, including head MRI data and Montreal Cognitive Assessment (MoCA) score. The cut-off points of MTA score and Koedam score were determined by using Receiver Operating Curve (ROC) and Youden Index. Multivariate analysis was performed to investigate variables which were associated with the cognitive function. </span></p> <p><strong><span>Result </span></strong><span>From 61 dementia patients, 22.95% was probable Alzheimer’s disease, 59.01% was vascular dementia, and 18.03% was mixed dementia. Correlation test showed that MTA and Koedam score were negatively associated with Montreal Cognitive Assessment-Indonesian Version (MoCA-INA) score. A bivariate analysis supports the findings that patients with combination of MTA score ≥3 and Koedam score ≥2 was more likely to have poor cognitive function (OR= 11.33; p<0.05). Multivariate analysis showed higher MTA (≥3) and Koedam (≥2) scores were associated with poor cognitive function in dementia patients (OR= 13.54, 95% CI= 1.77-103.43, <em>p</em>=0.01 and OR= 5.52, 95% CI= 1.08-28.19, <em>p</em>=0.04)</span></p> <p><strong><span>Conclusion </span></strong><span>Higher MTA and Koedam score contribute to worse cognitive function in any type of dementia patients. </span></p> <p><strong><span>Keywords.</span></strong><span> Imaging Marker, Medial Temporal Atrophy (MTA), Koedam Score, Cognitive Function, Dementia</span></p>
A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
ClinicalTrials.gov study NCT00276510. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
ClinicalTrials.gov study NCT06922188. IPD Sharing: NO. Countries: 1. Publications: 19.
Adapting Connect-Home Transitional Care for the Unique Needs of Persons With Alzheimer's Disease and Other Dementias and Their Caregivers
ClinicalTrials.gov study NCT05887388. IPD Sharing: YES. Countries: 1. Publications: 0.
DMB-I in the Treatment of Alzheimer Type Dementia
ClinicalTrials.gov study NCT06292351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acute Effect of Low-intensity Gamma rTMS on Cognitive and EEG Parameters in Adults With Mild Dementia by Alzheimer's Disease
ClinicalTrials.gov study NCT05784298. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia
ClinicalTrials.gov study NCT02360657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Optimal Medication Management in Alzheimer's Disease and Dementia
ClinicalTrials.gov study NCT03984396. IPD Sharing: NO. Countries: 1. Publications: 7.
European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
ClinicalTrials.gov study NCT02804789. IPD Sharing: YES. Countries: 9. Publications: 3.
18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls
ClinicalTrials.gov study NCT03625128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital
ClinicalTrials.gov study NCT07222449. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
ClinicalTrials.gov study NCT01822951. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
ClinicalTrials.gov study NCT02989402. IPD Sharing: YES. Countries: 1. Publications: 0.
Self and Autobiographical Memory in Dementia With Lewy Bodies and Alzheimer Disease: a Behavioral and Multimodal Neuroimaging Study
ClinicalTrials.gov study NCT04616287. IPD Sharing: NO. Countries: 1. Publications: 1.
Aerobic Exercise for Older Adults at Increased Risk of Alzheimer's Disease and Related Dementias
ClinicalTrials.gov study NCT03035851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
ClinicalTrials.gov study NCT05267535. IPD Sharing: NO. Countries: 2. Publications: 0.
Epileptic Activity in Patients With Alzheimer's Disease and Lewy Body Dementia
ClinicalTrials.gov study NCT04436341. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.